StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Agape ATP Corporation
NasdaqCM:ATPC
Sector
Industries
Location
Market Cap
USD 74.41 M
Share Price
USD 1.49
Avg Daily Volume
176,161
Change (1 day)
5.53%
Change (1 year)
Change (YTD)
60.87%
Agape ATP Corporation EBIT for the Trailing 12 Months (TTM) ending March 31, 2025: USD -2.57 M
Agape ATP Corporation EBIT is USD -2.57 M for the Trailing 12 Months (TTM) ending March 31, 2025, a 6.44% change year over year. EBIT means earnings before interest and taxes, it is calculated as operating income plus non-operating income.
-
Agape ATP Corporation EBIT for the Trailing 12 Months (TTM) ending March 31, 2024 was USD -2.41 M, a 40.79% change year over year.
-
Agape ATP Corporation EBIT for the Trailing 12 Months (TTM) ending March 31, 2023 was USD -1.71 M, a -4.10% change year over year.
-
Agape ATP Corporation EBIT for the Trailing 12 Months (TTM) ending March 31, 2022 was USD -1.79 M, a 424.23% change year over year.
-
Agape ATP Corporation EBIT for the Trailing 12 Months (TTM) ending March 31, 2021 was USD -341.13 K, a -70.63% change year over year.
Competitors
Eli Lilly and Company
USD 793.01
LLY
+2.36
0.30%
Johnson & Johnson
USD 156.90
JNJ
-0.79
-0.50%
AbbVie Inc.
USD 192.45
ABBV
-2.55
-1.31%
Novo Nordisk A/S
USD 68.61
NOVO-B.CO
-2.69
-3.77%
Roche Holding AG
USD 343.65
RO.SW
-5.43
-1.55%
Novartis AG
USD 120.78
NOVN.SW
-3.44
-2.77%
Abbott Laboratories
USD 132.02
ABT
-1.58
-1.18%
AstraZeneca PLC
USD 140.89
AZN.L
-3.33
-2.31%
Merck & Co., Inc.
USD 83.36
MRK
-0.66
-0.79%
Amgen Inc.
USD 295.27
AMGN
-5.10
-1.70%
Pfizer Inc.
USD 25.65
PFE
-0.13
-0.50%
Gilead Sciences, Inc.
USD 109.64
GILD
-4.90
-4.28%
Vertex Pharmaceuticals Incorporated
USD 468.85
VRTX
-10.68
-2.23%
Sanofi
USD 97.05
SAN.PA
-1.42
-1.44%
Bristol-Myers Squibb Company
USD 46.86
BMY
-1.66
-3.42%
McKesson Corporation
USD 709.59
MCK
-4.95
-0.69%
GSK plc
USD 18.99
GSK.L
-0.75
-3.81%
Elevance Health Inc.
USD 340.67
ELV
-5.19
-1.50%
Chugai Pharmaceutical Co., Ltd.
USD 46.36
4519.T
-0.52
-1.11%
CSL Limited
USD 158.31
CSL.AX
-1.36
-0.85%
Key Data
| Date | EBIT | EBITDA | Net Income | EPS (Diluted) |
|---|
Competitors
Eli Lilly and Company
USD 793.01
LLY
+2.36
0.30%
Johnson & Johnson
USD 156.90
JNJ
-0.79
-0.50%
AbbVie Inc.
USD 192.45
ABBV
-2.55
-1.31%
Novo Nordisk A/S
USD 68.61
NOVO-B.CO
-2.69
-3.77%
Roche Holding AG
USD 343.65
RO.SW
-5.43
-1.55%
Novartis AG
USD 120.78
NOVN.SW
-3.44
-2.77%
Abbott Laboratories
USD 132.02
ABT
-1.58
-1.18%
AstraZeneca PLC
USD 140.89
AZN.L
-3.33
-2.31%
Merck & Co., Inc.
USD 83.36
MRK
-0.66
-0.79%
Amgen Inc.
USD 295.27
AMGN
-5.10
-1.70%
Pfizer Inc.
USD 25.65
PFE
-0.13
-0.50%
Gilead Sciences, Inc.
USD 109.64
GILD
-4.90
-4.28%
Vertex Pharmaceuticals Incorporated
USD 468.85
VRTX
-10.68
-2.23%
Sanofi
USD 97.05
SAN.PA
-1.42
-1.44%
Bristol-Myers Squibb Company
USD 46.86
BMY
-1.66
-3.42%
McKesson Corporation
USD 709.59
MCK
-4.95
-0.69%
GSK plc
USD 18.99
GSK.L
-0.75
-3.81%
Elevance Health Inc.
USD 340.67
ELV
-5.19
-1.50%
Chugai Pharmaceutical Co., Ltd.
USD 46.36
4519.T
-0.52
-1.11%
CSL Limited
USD 158.31
CSL.AX
-1.36
-0.85%